Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Intellipharmaceutics International Inc (IPCIF)

Intellipharmaceutics International Inc (IPCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,986
  • Shares Outstanding, K 33,093
  • Annual Sales, $ 70 K
  • Annual Income, $ -2,890 K
  • 60-Month Beta 1.00
  • Price/Sales 2.36
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade IPCIF with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.16
  • Most Recent Earnings $-0.06 on 10/16/23
  • Latest Earnings Date 10/13/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0255 +179.22%
on 03/14/24
0.0814 -12.53%
on 03/21/24
+0.0247 (+53.12%)
since 02/28/24
3-Month
0.0255 +179.22%
on 03/14/24
0.0814 -12.53%
on 03/21/24
+0.0118 (+19.87%)
since 12/28/23
52-Week
0.0012 +5,833.33%
on 05/09/23
0.1068 -33.33%
on 08/09/23
+0.0171 (+31.61%)
since 03/28/23

Most Recent Stories

More News
Intellipharmaceutics Announces Fiscal Year 2022 and First Quarter 2023 Results

/CNW/ - Intellipharmaceutics International Inc. (OTCQB: IPCIF) (TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in...

IPCIF : 0.0712 (+18.67%)
IPCI.TO : 0.0800 (-11.11%)
Intellipharmaceutics Announces Cease Trade Order

/CNW/ - Intellipharmaceutics International Inc. (OTCQB: IPCIF) (TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in...

IPCIF : 0.0712 (+18.67%)
IPCI.TO : 0.0800 (-11.11%)
Intellipharmaceutics Provides Update on Management Cease Trade Order Application and Anticipates Cease Trade Order

/CNW/ - Intellipharmaceutics International Inc. (OTCQB: IPCIF) (TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in...

IPCIF : 0.0712 (+18.67%)
IPCI.TO : 0.0800 (-11.11%)
Intellipharmaceutics Announces its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form and its Management Cease Trade Order Application

/CNW/ - Intellipharmaceutics International Inc. (OTCQB: IPCIF) (TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in...

IPCIF : 0.0712 (+18.67%)
IPCI.TO : 0.0800 (-11.11%)
Intellipharmaceutics Announces Second Quarter 2022 Results

TORONTO, ON / ACCESSWIRE / July 21, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research,...

IPCIF : 0.0712 (+18.67%)
IPCI.TO : 0.0800 (-11.11%)
Intellipharmaceutics Announces Delay in Filing Second Quarter Results Due July 15, 2022, The Financial Statements Will be Filed By July 21, 2022

TORONTO, ON / ACCESSWIRE / July 15, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research,...

IPCIF : 0.0712 (+18.67%)
IPCI.TO : 0.0800 (-11.11%)
Intellipharmaceutics Reports Director Election Results

TORONTO, ON / ACCESSWIRE / May 27, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research,...

IPCIF : 0.0712 (+18.67%)
IPCI.TO : 0.0800 (-11.11%)
Intellipharmaceutics Announces First Quarter 2022 Results

TORONTO, ON / ACCESSWIRE / April 14, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...

IPCIF : 0.0712 (+18.67%)
IPCI.TO : 0.0800 (-11.11%)
Intellipharmaceutics Announces Fiscal Year 2021 Results

TORONTO, ON / ACCESSWIRE / February 28, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...

IPCIF : 0.0712 (+18.67%)
IPCI.TO : 0.0800 (-11.11%)
Intellipharmaceutics Reports Director Election Results

TORONTO, ON / ACCESSWIRE / February 4, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...

IPCIF : 0.0712 (+18.67%)
IPCI.TO : 0.0800 (-11.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 0.0712
2nd Resistance Point 0.0712
1st Resistance Point 0.0712
Last Price 0.0712
1st Support Level 0.0712
2nd Support Level 0.0712
3rd Support Level 0.0712

See More

52-Week High 0.1068
Last Price 0.0712
Fibonacci 61.8% 0.0665
Fibonacci 50% 0.0540
Fibonacci 38.2% 0.0415
52-Week Low 0.0012

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar